Kirschbaum Mark 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed Oct 28, 2020
Insider Transaction Report
Form 4
Kirschbaum Mark
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2020-10-23+120,000→ 120,000 totalExercise: $3.77Exp: 2030-10-23→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest as to 40,000 shares on October 23, 2021, with the remainder vesting in 24 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.